腦植入市場規模、佔有率、成長分析、按產品、按應用、按最終用戶、按地區 - 行業預測，2025-2032 年

2023年全球腦植入市場規模為15.7億美元，從2024年的17.6億美元成長到2032年的44.2億美元，在預測期內（2025-2032年）預計複合年成長率為12.2。

由於技術進步和神經系統疾病發病率的增加，全球腦植入市場呈現上升趨勢。腦植入（神經假體）是重要的醫療設備，可與大腦相互作用來診斷和治療癲癇和帕金森氏症等各種疾病，並支持認知增強。Medtronic)、雅培實驗室 (Abbott Laboratories) 和波士頓科學公司 (Boston Scientific) 等領先公司正在大力投資研究以改進這些技術。設備小型化、增強型電極設計和人工智慧整合等技術創新正在提高大腦植入的功能和安全性。然而，有關同意和資料安全的道德問題必須解決。隨著對先進神經治療的需求增加，預計該市場將顯著成長。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管環境
• 案例研究
• 技術進步

腦植入市場規模：依產品分類

• 市場概況
• 腦深部電刺激療法
• 迷走神經刺激
• 反應性神經刺激

腦植入市場規模：依應用分類

• 市場概況
• 癲癇
• 帕金森氏症
• 阿茲海默症
• 思覺失調症
• 其他

腦植入市場規模：依最終用戶分類

• 市場概況
• 醫院
• 專科診所
• 其他

腦植入市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Medtronic（United States）
• Boston Scientific（United States）
• NeuroPace（United States）
• Renishaw（United Kingdom）
• Abbott Laboratories（United States）
• LivaNova（United Kingdom）
• Synchron（United States）
• NeuroSigma（United States）
• Functional Neuromodulation（Canada）
• Stimwave（United States）
• Aleva Neurotherapeutics（Switzerland）
• Synapse Biomedical（United States）
• Nevro Corporation（United States）
• NDI Medical（United States）
• Second Sight Medical Products（United States）
• Cochlear Limited（Australia）
• Stryker Corporation（United States）
• Nihon Kohden Corporation（Japan）
• Terumo Corporation（Japan）
• Edwards Lifesciences Corporation（United States）

結論和建議

Global Brain Implant Market size was valued at USD 1.57 billion in 2023 and is poised to grow from USD 1.76 billion in 2024 to USD 4.42 billion by 2032, growing at a CAGR of 12.2% during the forecast period (2025-2032).

The global brain implant market is on an upward trajectory, fueled by technological advancements and a growing incidence of neurological disorders. Brain implants, or neuroprosthetics, serve as crucial medical devices that interact with the brain to diagnose and treat various conditions, such as epilepsy and Parkinson's disease, while also supporting cognitive enhancement. Major players, including Medtronic, Abbott Laboratories, and Boston Scientific, are heavily investing in research to refine these technologies. Innovations like miniaturized devices, enhanced electrode designs, and artificial intelligence integration are boosting the functionality and safety of brain implants. However, ethical issues related to consent and data security must be navigated. The market is expected to witness significant growth as the demand for advanced neurological treatments escalates.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Brain Implant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Brain Implant Market Segmental Analysis

Global Brain Implant Market is segmented by product, application, end user and region. Based on product, the market is segmented into Deep Brain Stimulation, Vagus Nerve Stimulation and Responsive Neurostimulation. Based on application, the market is segmented into Epilepsy, Parkinson's Disease, Alzheimer's Disease, Schizophrenia and others. Based on end user, the market is segmented into hospitals, specialty clinics and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Brain Implant Market

The Global Brain Implant market is significantly propelled by the growing prevalence of neurological disorders like Parkinson's disease, epilepsy, and chronic pain. As more individuals are diagnosed with these conditions, the demand for brain implant technologies is surging, as they provide innovative solutions for symptom management and enhance overall patient well-being. These advanced implants not only help alleviate discomfort but also greatly improve the quality of life for those affected by these debilitating disorders. Consequently, the increasing rate of neurological diseases continues to be a vital driver for the expansion and development within the brain implant sector.

Restraints in the Global Brain Implant Market

The Global Brain Implant market faces several restraints stemming from ethical and privacy issues. As brain implants become more prevalent, concerns about informed consent and the safeguarding of individuals' private data are critically important. The invasive nature of these procedures heightens the risks associated with their implementation, which necessitates a thorough evaluation of the potential advantages against the long-term implications for patients' well-being. Furthermore, there is apprehension regarding the possible misuse of the data obtained from brain implants, compelling stakeholders to navigate these ethical dilemmas while ensuring that patient autonomy and confidentiality remain protected in this evolving field.

Market Trends of the Global Brain Implant Market

One key market trend in the global brain implant market is the growing emphasis on miniaturization and wireless connectivity of implantable devices. Technological advancements are fostering the creation of smaller, more compact brain implants, which significantly minimize the invasiveness of surgical procedures and enhance patient comfort. These miniaturized devices facilitate minimally invasive methods and improve the feasibility of long-term implantation, as they reduce the risk of complications associated with larger implants. Additionally, the integration of wireless connectivity allows for seamless data transmission and remote monitoring, making brain implants more user-friendly and appealing to both patients and healthcare providers, ultimately driving market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Brain Implant Market Size by Product & CAGR (2025-2032)

• Market Overview
• Deep Brain Stimulation
• Vagus Nerve Stimulation
• Responsive Neurostimulation

Global Brain Implant Market Size by Application & CAGR (2025-2032)

• Market Overview
• Epilepsy
• Parkinson'S Disease
• Alzheimer'S Disease
• Schizophrenia
• Others

Global Brain Implant Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Brain Implant Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Renishaw (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synchron (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Functional Neuromodulation (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stimwave (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva Neurotherapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synapse Biomedical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NDI Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Second Sight Medical Products (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cochlear Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations